Presenting author

Andy Czysz

1 presentation

• S15.07. Muscarinic agonism with ML-007C-MA for the treatment of schizophrenia: results from the phase 2 randomized, double-blind, placebo-controlled ZEPHYR trial

  2026 ECNP Congress